⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17828437 | 0.98 | — | — | |
| SCHEMBL17828448 | 0.91 | DNM1 (0.34) | — | |
| SCHEMBL17828440 | 0.91 | — | — | |
| SCHEMBL8998612 | 0.86 | — | — | |
| SCHEMBL17828436 | 0.78 | — | — | |
| SCHEMBL8760414 | 0.73 | LMNA (0.33) | — | |
| SCHEMBL13303192 | 0.72 | DNM1 (0.33) | — | |
| Pentane SCHEMBL4440624 | 0.72 | LMNA (0.47) | — | |
| Perflexane SCHEMBL6291254 | 0.72 | LMNA (0.47) | — | |
| Perflexane SCHEMBL17714361 | 0.72 | TSHR (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4065086-A1 | SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS EMULSIONS | REGENERON PHARMACEUTICALS, INC. (US) | 2022-10-05 | — | — | EP | claimed |
| US-9513207-B2 | Emulsion | SPHERE FLUIDICS LIMITED (GB) | 2016-12-06 | — | — | US | disclosed |
| US-20160252446-A1 | MICROFLUIDIC DEVICES AND SYSTEMS | SPHERE FLUIDICS LIMITED (GB) | 2016-09-01 | — | — | US | disclosed |
| US-20160169788-A1 | EMULSION | SPHERE FLUIDICS LIMITED (GB) | 2016-06-16 | — | — | US | disclosed |